The impact of diabetes type 2 in the pathogenesis of benign prostatic hyperplasia: a review.
about
Comparative analysis of resected prostate weight in diabetic and non-diabetic benign prostatic hyperplasia Patients.Thiazolidinedione and Metformin Use and the Risk of Benign Prostate Hyperplasia in Veterans with Diabetes Mellitus.Towards the prevention and management of prostatic diseases in Nigeria: a framework.Benign prostatic hyperplasia complicated with T1DM can be alleviated by treadmill exercise-evidences revealed by the rat modelDemographic and comorbidity profile of patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a real-life clinical setting: Are 5-alpha-reductase inhibitor consumers different?Metformin: an anti-proliferative agent and methylation regulator in treating prostatic disease?
P2860
The impact of diabetes type 2 in the pathogenesis of benign prostatic hyperplasia: a review.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The impact of diabetes type 2 ...... ostatic hyperplasia: a review.
@ast
The impact of diabetes type 2 ...... ostatic hyperplasia: a review.
@en
type
label
The impact of diabetes type 2 ...... ostatic hyperplasia: a review.
@ast
The impact of diabetes type 2 ...... ostatic hyperplasia: a review.
@en
prefLabel
The impact of diabetes type 2 ...... ostatic hyperplasia: a review.
@ast
The impact of diabetes type 2 ...... ostatic hyperplasia: a review.
@en
P2093
P2860
P356
P1433
P1476
The impact of diabetes type 2 ...... ostatic hyperplasia: a review.
@en
P2093
E Kostakos
V Koutsonasios
P2860
P304
P356
10.1155/2009/818965
P577
2009-11-09T00:00:00Z